Dr Christopher Howard
Dr

Christopher Howard

Email: 
Phone: 
+61 7 334 64209

Availability

Dr Christopher Howard is:
Available for supervision

Qualifications

  • Doctor of Philosophy, Queensland University of Technology

Research interests

  • Protein engineering, Programmable Bionanomaterials, Molecular Discovery, Bio Nano Technologies

Search Professor Christopher Howard’s works on UQ eSpace

81 works between 2005 and 2025
All (81) Journal Article (77) Conference Publication (4)

81 - 81 of 81 works

2005

Journal Article

Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production

Johnson, BJ, Le, TTT, Dobbin, CA, Banovic, T, Howard, CB, Flores, FDL, Vanags, D, Naylor, DJ, Hill, GR and Suhrbier, A (2005). Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. Journal of Biological Chemistry, 280 (6), 4037-4047. doi: 10.1074/jbc.M411569200

Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production

Current funding

  • 2025 - 2027
    "COVID & Beyond": Innovative rapid response nanoprobes to detect the next pandemic threat.
    NHMRC IDEAS Grants
    Open grant
  • 2023 - 2025
    Research and Development of Membrane Technology
    Aegros Biopharma Pty Ltd
    Open grant

Past funding

  • 2022 - 2025
    An integrated nano-bioengineered chip for enhanced molecular evolution
    ARC Discovery Projects
    Open grant
  • 2021 - 2024
    Innovative delivery methods for the biologic soluble RAGE to prevent Type 1 Diabetes
    JDRF Pilot and Innovation Awards
    Open grant
  • 2020 - 2023
    Novel Virus Trap Nanotechnology for COVID-19 Detection
    Advance Queensland Industry Research Fellowships
    Open grant
  • 2019 - 2022
    Smart affinity membranes for manufacture of high value therapeutic proteins
    ARC Linkage Projects
    Open grant
  • 2019 - 2020
    Evaluation of recombinant biologics for immune modulation
    Servatus Biopharmaceuticals
    Open grant
  • 2019
    Production and analysis of recombinant therapeutics for immune modulation
    Servatus Biopharmaceuticals
    Open grant
  • 2019
    Expression of recombinant proteins in mammalian cells
    Servatus Biopharmaceuticals
    Open grant
  • 2018
    Continuous chromatography system for advanced bioprocessing
    UQ Major Equipment and Infrastructure
    Open grant
  • 2017 - 2018
    Provision of research services to Minomic International Ltd
    Minomic International Ltd
    Open grant
  • 2017 - 2023
    ARC Training Centre for Biopharmaceutical Innovation
    ARC Industrial Transformation Training Centres
    Open grant
  • 2016 - 2017
    EGFR targeted nanoparticle feasibility study
    Samyang Biopharmaceuticals Corporation
    Open grant
  • 2016 - 2019
    Next generation hybrid nanomaterials: bispecific antibody-targeted polymers
    ARC Linkage Projects
    Open grant
  • 2016 - 2018
    Immuno-polymeric drugs for prostate cancer therapy
    NHMRC Project Grant
    Open grant

Availability

Dr Christopher Howard is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

Supervision history

Current supervision

  • Doctor Philosophy

    Engineering synthetic regulatory circuits for precise metabolic control in Saccharomyces cerevisiae

    Principal Advisor

    Other advisors: Professor Gary Schenk

  • Doctor Philosophy

    Development of next-generation molecular tools for diagnostics

    Principal Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    Surface engineering of nanoyeast

    Principal Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    Development of next-generation molecular tools for diagnostics

    Principal Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    Engineering synthetic regulatory circuits for precise metabolic control in Saccharomyces cerevisiae

    Principal Advisor

    Other advisors: Professor Gary Schenk

  • Doctor Philosophy

    Engineering Novel Theranostics for High Grade Glioma Through Site-Specific EphA2 Antibody Modification

    Associate Advisor

    Other advisors: Emeritus Professor Stephen Mahler, Dr Martina Jones

  • Doctor Philosophy

    Engineering Novel Theranostics for High Grade Glioma Through Site-Specific EphA2 Antibody Modification

    Associate Advisor

    Other advisors: Emeritus Professor Stephen Mahler, Dr Martina Jones

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Associate Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    mRNA cancer therapies

    Associate Advisor

    Other advisors: Professor Timothy Mercer, Associate Professor Seth Cheetham

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Associate Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    Investigating therapeutic potentials of brain-derived exosomes

    Associate Advisor

    Other advisors: Professor Matt Trau, Dr Richard Lobb

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Associate Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    An integrated nano-bioengineered chip for enhanced molecular evolution

    Associate Advisor

    Other advisors: Professor Matt Trau

  • Doctor Philosophy

    Integration of innovative diagnostic technologies for the detection of flaviviral infections

    Associate Advisor

    Other advisors: Associate Professor Jody Peters

  • Doctor Philosophy

    Integration of innovative platform technologies for the diagnosis of flaviviral infections

    Associate Advisor

    Other advisors: Associate Professor Jody Peters

Completed supervision

Enquiries

For media enquiries about Dr Christopher Howard's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au